Table 4.
Variable | n | Responders | Non responders |
Among responders |
|
Sustained response | Relapse | ||||
Severe Fibrosis | |||||
A1 | 13 | 8 (61.5) | 5 (38.5) | 5 (62.5) | 3 (37.5) |
B2 | 11 | 1 (9.1) | 10 (90.9) | 0 (0.0) | 1 (100.0) |
Mild fibrosis | |||||
A1 | 25 | 21 (84.0) | 4 (15.0) | 20 (95.2) | 1 (4.8) |
B2 | 24 | 13 (54.2) | 11 (45.8) | 9 (69.2) | 4 (30.8) |
Severe inflammation | |||||
A1 | 31 | 22 (71.0) | 9 (29.0) | 18 (81.8) | 4 (18.2) |
B2 | 27 | 7 (25.9) | 20 (74.1) | 4 (57.1) | 3 (42.9) |
Mild inflammation | |||||
A1 | 7 | 7 (100.0) | 0 (0.0) | 7 (100.0) | 0 (0.0) |
Group A = PEG-IFN+RBV;
Group B = IFN + RBV.